Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jun 1;207(11):1418-1419.
doi: 10.1164/rccm.202303-0580ED.

An ALARMINg Type 2 Response in Cystic Fibrosis-The Key to Understanding ABPA?

Affiliations
Editorial

An ALARMINg Type 2 Response in Cystic Fibrosis-The Key to Understanding ABPA?

Christine M Bojanowski et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Bojanowski CM, Lu S, Kolls JK. Mucosal immunity in cystic fibrosis. J cImmunol . 2021;207:2901–2912. - PMC - PubMed
    1. Allen L, Allen L, Carr SB, Davies G, Downey D, Egan M, et al. Future therapies for cystic fibrosis. Nat Commun . 2023;14:693. - PMC - PubMed
    1. Kreindler JL, Steele C, Nguyen N, Chan YR, Pilewski JM, Alcorn JF, et al. Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis. J Clin Invest . 2010;120:3242–3254. - PMC - PubMed
    1. Agarwal R, Khan A, Aggarwal AN, Gupta D. Link between CFTR mutations and ABPA: a systematic review and meta-analysis. Mycoses . 2012;55:357–365. - PubMed
    1. Cook DP, Thomas CM, Wu AY, Rusznak M, Zhang J, Zhou W, et al. Cystic fibrosis reprograms airway epithelial IL-33 release and licenses IL-33 dependent inflammation. Am J Respir Crit Care Med . 2023;207:1486–1497. - PMC - PubMed

Publication types